Vanguard Group Inc Abeona Therapeutics Inc. Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
A detailed history of Vanguard Group Inc transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,020,185 shares of ABEO stock, worth $12.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,020,185
Previous 1,966,023
2.75%
Holding current value
$12.6 Million
Previous $10.9 Million
11.87%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding ABEO
# of Institutions
77Shares Held
27.8MCall Options Held
556KPut Options Held
34.9K-
Suvretta Capital Management, LLC New York, NY3.69MShares$23 Million0.77% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.51MShares$21.9 Million0.75% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.69MShares$16.8 Million0.02% of portfolio
-
Western Standard LLC Los Angeles, CA2.28MShares$14.2 Million6.48% of portfolio
-
Vivo Capital, LLC Palo Alto, CA1.84MShares$11.5 Million2.38% of portfolio
About ABEONA THERAPEUTICS INC.
- Ticker ABEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,950,380
- Market Cap $37.1M
- Description
- Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...